Moody Aldrich Partners LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 936941
MARBLEHEAD, MA
Position in MDGL
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$2,004,366
-$252,783 QoQ
Shares Held
3,829
-1.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 36%
Shared 29%
None 34%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moody Aldrich Partners LLC holds $91,411,685 across 28 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
101,411 | $9,651,284 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
28,160 | $8,901,094 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
59,601 | $7,305,890 | |
| 4 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
74,552 | $7,267,328 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
19,066 | $6,383,106 | |
| 6 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
146,077 | $5,466,201 | |
| 7 | NKTR |
Nektar Therapeutics
|
64,135 | $4,477,264 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
177,754 | $4,280,316 |
All Filings in MDGL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,004,366 | 3,829 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,257,149 | 3,876 | Shares | Sole | 2026-01-30 | |
| 2024-06-30 | $1,348,690 | 4,814 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,368,312 | 5,124 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,134,017 | 9,223 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,983,077 | 13,579 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,523,906 | 10,926 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,739,426 | 7,180 | Shares | Sole | 2023-04-27 | |
| No filing history on record for this holder in this stock. | ||||||